Results 1 to 10 of about 3,329 (118)
Management of bipolar depression
Indian Journal of Psychological Medicine, 2011 Patients with bipolar disorder spend more time in a depressed than manic state, even with individualized treatment. To date, bipolar depression is often misdiagnosed and ineffectively managed both for acute episodes and residual symptoms.
Jae Seung Chang, Kyooseob Ha
doaj +2 more sources
Novel treatment options in depression and psychosis
Neuropsychiatric Disease and Treatment, 2018 Eva Ceskova, Petr Silhan Department of Psychiatry, University Hospital Ostrava, Ostrava, Czech Republic Abstract: In spite of tremendous development in central nervous system research, current treatment is suboptimal, especially in severe mental ...
Ceskova E, Silhan P
doaj +1 more source
Efficacy of bupropion and cognitive behavioral therapy in the treatment of methamphetamine use disorder: a systematic review and meta-analysis [PDF]
Brazilian Journal of Psychiatry, 2023 Objectives: We assessed the efficacy of cognitive behavioral therapy and bupropion compared to cognitive behavioral therapy alone for methamphetamine use disorder. Methods: The selection criteria for this systematic review study with meta-analysis were
Luis Fernando Maya Apuy +2 more
doaj +1 more source
Adjunctive antidepressive pharmacotherapy in schizophrenia patients
European Psychiatry, 2021 Depressive symptoms during long-term course of schizophrenia constitute an important and frequent clinical problem. They may occur either as stand-alone major depressive episodes (MDEs) or as part of the schizophrenic negative syndrome.
M. Zink
doaj +1 more source
Anxiolytic and antidepressant effect of zinc on rats and its impact on general behavioural parameters [PDF]
Vojnosanitetski Pregled, 2013 Background/Aim. Zinc is an essential element which has considerable interaction with gamma-aminobutyric acid A type receptors (GABAA) and glutamate receptors in the central nervous system (CNS).
Samardžić Janko +8 more
doaj +1 more source
Frontiers in Psychiatry, 2020 BackgroundAntidepressant treatment is one of the most effective ways of relieving or curing depressive symptoms in patients with major depressive disorder (MDD).
Li Duan +7 more
doaj +1 more source
Klassifizierung psychotroper Substanzen nach deren Wirkung auf das Corticale und Hippocampale Wach-EEG der Ratte [PDF]
, 1986 An chronisch mit Ableitelektroden im parietalen Cortex und im dorsalen Hippocampus versehenen Ratten wurde die Wirkung verschiedener i.p. Dosen von Referenzpsychopharmaka auf das quantifizierte EEG untersucht.
Dürmüller, Niklaus
core +1 more source
, 2020 Contexte La pratique de l’électroconvulsivothérapie (ECT) est de plus en plus codifiée (recommandations portant sur les indications, contre-indications, modalités de réalisation, locaux adaptés, réglementations pour l’anesthésie).
THOMAS, P. +7 more
core +1 more source
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
, 2009 Fluvoxamine, one of the oldest selective serotonin reuptaking inhibitors, is commonly prescribed to patients with major depression. Several studies have reviewed the efficacy and tolerability of fluvoxamine for the treatment of major depression. However,
McGuire, H +18 more
core +1 more source
Pharmacotherapy of schizophrenia and comorbid substance use disorder
, 2008 Substance use disorder is the most common psychiatric comorbidity in patients with schizophrenia, revealing prevalence rates of up to 65%. Recommendations of antipsychotic pharmacotherapy in schizophrenia are based on studies excluding patients with this
Falkai, Peter Gaston +5 more
core +1 more source